Millennium Management’s Design Therapeutics DSGN Stock Holding History

Millennium Management’s Portfolio DSGN Stock Details DSGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Sell	108,928 -71,938	-40%	-$728K	﹤0.01%	4287
2025 Q4	$1.7M	Buy	180,866 +112,043	+163%	+$877K	﹤0.01%	4085
2025 Q3	$518K	Buy	+68,823	New	+$345K	﹤0.01%	5044
2025 Q2	–	Sell	-87,988	Closed	-$340K	–	5955
2025 Q1	$340K	Buy	+87,988	New	+$420K	﹤0.01%	5027
2024 Q4	–	Sell	-207,257	Closed	-$1.12M	–	6051
2024 Q3	$1.12M	Sell	207,257 -403,546	-66%	-$1.9M	﹤0.01%	4179
2024 Q2	$2.05M	Buy	610,803 +126,335	+26%	+$492K	﹤0.01%	3524
2024 Q1	$1.95M	Buy	484,468 +64,405	+15%	+$172K	﹤0.01%	3761
2023 Q4	$1.11M	Sell	420,063 -409,417	-49%	-$938K	﹤0.01%	4067
2023 Q3	$1.96M	Buy	829,480 +549,601	+196%	+$2.56M	﹤0.01%	3569
2023 Q2	$1.76M	Sell	279,879 -510,334	-65%	-$3.12M	﹤0.01%	3595
2023 Q1	$4.56M	Buy	790,213 +273,402	+53%	+$2.04M	﹤0.01%	2693
2022 Q4	$5.3M	Buy	516,811 +375,313	+265%	+$5.09M	﹤0.01%	2760
2022 Q3	$2.37M	Buy	+141,498	New	+$2.82M	﹤0.01%	3600
2021 Q4	–	Sell	-14,169	Closed	-$208K	–	6920
2021 Q3	$208K	Buy	+14,169	New	+$236K	﹤0.01%	6089
2021 Q2	–	Sell	-253,037	Closed	-$7.57M	–	6628
2021 Q1	$7.57M	Buy	+253,037	New	+$8.53M	0.01%	2099

Other funds holding DSGN

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management's DSGN Position: Q1 2026 in Review

Millennium Management reduced its Design Therapeutics (DSGN) stake by 40% in Q1 2026, selling an estimated $728K and leaving 108,928 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #4287.

Millennium Management first reported a position in DSGN in Q1 2021 and has held it in 15 quarters since. The position peaked at $7.57M in Q1 2021. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

Millennium Management held 108,928 shares of Design Therapeutics worth $1.16M as of Q1 2026.
Millennium Management sold 71,938 Design Therapeutics shares in Q1 2026, an estimated $728K.
Design Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4287 holding.
Millennium Management first reported a position in Design Therapeutics in Q1 2021 and has held it in 15 quarters since.
Millennium Management's Design Therapeutics position peaked at $7.57M in Q1 2021.
125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.